Abstract
Giant Cell Arteritis (GCA) is the most common systemic vasculitis. It targets large and medium caliber vessels and its classic symptoms result from a predilection for the cranial branches of the carotid arteries. It is a disorder of middle to older age and rarely affects individuals younger than 50. Diagnostic dilemmas frequently result from clinical presentations that can be highly variable and diagnostic tests that are often nonspecific or unreliable. The consequences of missing the diagnosis are high, with permanent vision loss occurring in 15–20% of patients. However, because it is a disease of older patients, often with medical comorbidities, standard treatment with systemic corticosteroids is far from benign in many cases. Accurate diagnosis and effective treatment require a high index of suspicion in nonspecific presentations, careful examination and diagnostic workup and, at times, tolerance for uncertainty in choosing the best clinical approach for each patient in which GCA is suspected.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
González-Gay MA, García-Porrúa C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore). 1999;78:292–308.
Docken WP, Rosenbaum JT. Clinical manifestations of giant cell arteritis. In: Ramirez Curtis M, editor. UpToDate. Waltham, MA: UpToDate Inc. http://www.uptodate.com. Accessed on May 9, 2018.
Hunder G. The early history of giant cell arteritis and polymyalgia Rheumatica: first descriptions to 1970. Mayo Clin Proc. 2006;81(8):1071–83.
Hutchinson J. Diseases of the arteries. Arch Surg (London). 1889–90;1:323.
Horton BT, Magath TB, Brown GE. An Undescribed form of arteritis of the temporal vessels. Proc Staff Meet Mayo Clin. 1932;7:700–1.
Horton BT, Magath TB, Brown GE. Arteritis of the temporal vessels: previously undescribed form. Arch Int Med. 1934;53:400–9.
Horton BT, Magath TB. Arteritis of the temporal vessels: report of 7 cases. Proc Staff Meet Mayo Clin. 1937;12:548–53.
Horton BT. The temporal arteritis story: discovery of a new entity, Horton’s disease. Boswell Hosp Proc. 1979;5:60–71.
Wagener HP, Hollenhorst RW. The ocular lesions of temporal arteritis. Am J Ophthalmol. 1958;45:617–30.
Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61(10):1454–61.
Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum. 1983 Oct;26(10):1214–9.
Ostberg G. An arteritis with special reference to Polymyalgia Arteritica. Acta Pathol Microbiol Scand Suppl. 1973;237(Suppl 237):1.
Smetana GW, Shmerling RH. Does this patient have temporal arteritis. JAMA. 2002;287(1):92–101.
Solomon S, Cappa KG. The headache of temporal arteritis. J Am Geriatr Soc. 1987;35:163–5.
Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore). 2005;84(5):269–76.
Salvarani C, Cantini F, Olivieri I, Barozzi L, Macchioni L, Niccoli L, Padula A, De Matteis M, Pavlica P. Proximal bursitis in active polymyalgia Rheumatica. Ann Intern Med. 1997;127(1):27–31.
Arnow PM, Flaherty JP. Fever of unknown origin. Lancet. 1997;350(9077):575–80.
Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S, Garcia-Porrua C, Sanchez-Andrade A, Paz-Carreira J, Martin J, Llorca J. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore). 2005;84(5):277–90.
Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study. Arthritis Rheum. 2001;45(2):140–5.
Liozon E, Jauberteau-Marchan MO, Ly K, Loustaud-Ratti V, Soria P, Vidal E. Giant cell arteritis with a low erythrocyte sedimentation rate: comments on the article by Salvarani and Hunder. Arthritis Rheum. 2002;47(6):692–3.
Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, Warrington KJ. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012;41(6):866.. Epub 2011 Nov 25–71.
Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 1993;36(9):1286–94.
Weyand CM, Goronzy JJ. Medium- and large-vessel Vasculitis. N Engl J Med. 2003;349(2):160–9.
Borchers AT, Gershwin ME. Giant cell arteritis: a review of the classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev. 2012;11(6–7):A544–54. https://doi.org/10.1016/j.autrev.2012.01.003.. Epub 2012 Jan 21
Salvarani C, Giannini C, Miller DV, Hunder G. Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum. 2006;55(6):985–9.
Soriano A, Muratore F, Pipitone N, Boiardi L, Cimino L, Salvarani C. Visual loss and other cranial ischaemic complications in giant cell arteritis. Nat Rev Rheumatol. 2017;13(8):476–84. https://doi.org/10.1038/nrrheum.2017.98.. Epub 2017 Jul 6
Biousse V, Newman N. Ischemic optic neuropathies. N Engl J Med. 2015;372:2428–36.
Rüegg S, Engelter S, Jeanneret C, Hetzel A, Probst A, Steck AJ, Lyrer P. Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine (Baltimore). 2003;82(1):1–12.
Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, Pego-Reigosa R, Lopez-Diaz MJ, Vazquez-Triñanes MC, Miranda-Filloy JA, Blanco R, Dierssen T, Gonzalez-Juanatey C, Llorca J. Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis. Medicine (Baltimore). 2009;88(4):227–35. https://doi.org/10.1097/MD.0b013e3181af4518.
Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia Rheumatica and giant cell arteritis: a systematic review. JAMA. 2016;315(22):2442–58. https://doi.org/10.1001/jama.2016.5444.
Docken WP. Diagnosis of giant cell arteritis. Ramirez Curtis M, editor. UpToDate. Waltham, MA: UpToDate Inc. http://www.uptodate.com Accessed on May 9, 2018.
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377(4):317–28.
Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology. 2003;110(6):1204–15.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gaines, N., Liebeskind, D.S. (2020). Giant Cell Arteritis. In: Park, M., Kalani, M., de Havenon, A., McNally, J. (eds) Carotid Artery Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-41138-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-41138-1_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41137-4
Online ISBN: 978-3-030-41138-1
eBook Packages: MedicineMedicine (R0)